A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line…
Month: January 2025
212 posts
Breaking Down the Safety of BCG in Patients With NMIBC
BCG therapy is associated with a high frequency of side effects in…
Why Hope is Important For Patients with Chronic Lymphocytic Leukemia
Hope is crucial for those of us with chronic lymphocytic leukemia, or…
Three Ways to Manage Burnout at Work
Managing burnout is a critical concern for many professionals, especially those diagnosed…
Dwayne Wade Talks Tumor Removal, Bachelorette Star’s Husband Cancer Diagnosis and More
From the reveal of NBA star Dwayne Wade’s cancer surgery to a…
Keytruda and Lenvima Combo Misses OS Mark in HER2– Gastroesophageal Cancer
In the LEAP-015 trial, Keytruda and Lenvima plus chemo did not meet…
Galinpepimut-S Immunotherapy Has Preliminary Efficacy in Acute Myeloid Leukemia
Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid…
Herceptin Combo Shows Limited Benefit in Gastric/GEJ Cancer
In the INNOVATION trial, adding Herceptin and Perjeta to chemotherapy increased toxicity…
Research Spotlight: Advances in Pancreatic Cancer Research and Key Insights from ASCO GI 2025
Jan 30, 2025 – By Anna Berkenblit, MD, MMSc Editor’s note: The…
How Many Victims of Mesothelioma Are There?
Mesothelioma affects tens of thousands of people around the world. Check out…
Strutting Into Year 11 With Metastatic Breast Cancer
After living with metastatic breast cancer for 11 years, I reflect on…
How Do Molecular Factors Impact Response to Immunotherapy in Kidney Cancer?
Dr. David A. Braun delved into the molecular factors which drive exceptional…